Cetirizine Hydrochloride/Sodium Cromoglicate

盐酸西替利嗪/色甘酸钠

Report date: 2022/07/04 19:38:02

Base Information

Drug NameCetirizine Hydrochloride/Sodium Cromoglicate
Drug Alias NameCromoglicic acid sodium+Cetirizine
ClassificationSmall molecules
Mechanisms of ActionHistamine H1 receptor antagonistsMast cells stabilizersGlial cells modulators
TargetsHistamine H1 receptor
Therapy Area/IndicationsProstatitis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesNorthwest University
China Registration ClassN/A

Develop Information

Active CompaniesNorthwestern University
Inactive CompaniesN/A
Active IndicationsProstatitis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A